Trastuzumab: tested in a combination

382 studies: another drug in the study is under test too. Page 4 of 4. Open to participants first (81), then studies with results posted, then the rest; newest registration first within each.

• Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and TrastuzumabCompletedNCT01432223Phase 2Report a problem
• Weekly Paclitaxel and Trastuzumab in Metastatic Breast CancerCompletedNCT01423695Phase 2Report a problem
• Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast CancerCompletedNCT01413828Phase 2/3Report a problem
• Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOXCompletedNCT01396707Phase 2Report a problem
• Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast CancerCompletedNCT01387373Phase 2Report a problem
• A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerCompletedNCT01364493Phase 2Report a problem
• Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2Report a problem
• Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast CancerStatus unknownNCT01321775Phase 2Report a problem
• Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable CancerCompletedNCT01295086Not applicableReport a problem
• Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast CancerCompletedNCT01242449Phase 2Report a problem
• A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerStatus unknownNCT01228045Phase 2Report a problem
• Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast CancerCompletedNCT01206881Phase 2Report a problem
• Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic AdenocarcinomaCompletedNCT01204372Phase 2Report a problem
• A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast CancerWithdrawnNCT01163929Phase 2Report a problem
• A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast CancerWithdrawnNCT01137994Phase 2Report a problem
• National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]CompletedNCT01104935Phase 3Report a problem
• Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast CancerActive, not recruitingNCT01104571Phase 3Report a problem
• A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerWithdrawnNCT00964704Phase 2Report a problem
• Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow MicrometastasesCompletedNCT00949247Early Phase 1Report a problem
• Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineCompletedNCT00923299Phase 1/2Report a problem
• Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast CancerStatus unknownNCT00842998Phase 2Report a problem
• Study of Neoadjuvant Chemotherapy of Breast CancerStatus unknownNCT00830544Phase 2Report a problem
• Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)CompletedNCT00795899Phase 2Report a problem
• Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN StudyCompletedNCT00768859Phase 2Report a problem
• Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast CancerCompletedNCT00615602Phase 3Report a problem
• The Synergism Or Long Duration (SOLD) StudyCompletedNCT00593697Phase 3Report a problem
• Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast CancerCompletedNCT00535509Not applicableReport a problem
• Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabCompletedNCT00532857Phase 2Report a problem
• Phase II Study in Patients With Operable Breast CancerStatus unknownNCT00518583Phase 2Report a problem
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast CancerStatus unknownNCT00486668Phase 3Report a problem
• CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2Report a problem
• VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast CancerStatus unknownNCT00431704Phase 2Report a problem
• Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast CarcinomaTerminatedNCT00403988Phase 2Report a problem
• HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast CancerCompletedNCT00401427Phase 2Report a problem
• Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2Report a problem
• Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2Report a problem
• Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast CancerStatus unknownNCT00367250Phase 1Report a problem
• Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast CancerCompletedNCT00303992Phase 2Report a problem
• Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00288002Phase 3Report a problem
• Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast CancerStatus unknownNCT00250874Phase 2Report a problem
• Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast CancerCompletedNCT00238290Phase 2Report a problem
• Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast CancerTerminatedNCT00216073Phase 2Report a problem
• PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2CompletedNCT00199212Phase 1Report a problem
• Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast CancerCompletedNCT00193089Phase 2Report a problem
• Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast CancerCompletedNCT00193076Phase 2Report a problem
• A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseCompletedNCT00191373Phase 2Report a problem
• Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast CancerTerminatedNCT00171847Phase 4Report a problem
• Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2Report a problem
• Preoperative Herceptin and Navelbine for Breast CancerCompletedNCT00148681Phase 2Report a problem
• Neoadjuvant Therapy With Herceptin and Taxol for Breast CancerCompletedNCT00136539Phase 2Report a problem
• Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBCCompletedNCT00134680Phase 2Report a problem
• Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer PatientsCompletedNCT00129896Phase 1/2Report a problem
• Trastuzumab and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00107393Phase 2Report a problem
• Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCompletedNCT00103233Phase 3Report a problem
• Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)CompletedNCT00095706Phase 1/2Report a problem
• Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing CancerCompletedNCT00084513Phase 1Report a problem
• Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNCT00057993Phase 2Report a problem
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00054587Phase 3Report a problem
• Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00036868Phase 2Report a problem
• Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast CancerCompletedNCT00024154Phase 2Report a problem
• Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00019812Phase 2Report a problem
• Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00016367Phase 2Report a problem
• Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTerminatedNCT00016276Phase 3Report a problem
• Chemotherapy Plus Trastuzumab in Treating Patients With Breast CancerCompletedNCT00014430Phase 1Report a problem
• Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00009997Phase 1Report a problem
• Celecoxib and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00006381Phase 2Report a problem
• Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00006108Phase 1/2Report a problem
• Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00006104Phase 2Report a problem
• Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal CancerTerminatedNCT00006015Phase 2Report a problem
• Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerCompletedNCT00005970Phase 3Report a problem
• Gemcitabine, Herceptin and Radiation to Treat Cancer of the PancreasCompletedNCT00005926Phase 2Report a problem
• Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone TherapyCompletedNCT00005857Phase 2Report a problem
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2Report a problem
• Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00005635Phase 2Report a problem
• Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerCompletedNCT00004013Phase 2Report a problem
• Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2CompletedNCT00003992Phase 2Report a problem
• Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003881Phase 2Report a problem
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the PancreasStatus unknownNCT00003797Phase 2Report a problem
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2Report a problem
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00003539Phase 2Report a problem
• Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticCompletedNCT00003440Phase 3Report a problem
• Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid TumorsCompletedNCT00002994Phase 1Report a problem

← Trastuzumab